TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
苏雷什· K.
4天前
Farhan Q.
2 个月前
Neha S.
2 周前